Intensive Nitrogen Mustard Therapy for Nasopharyngeal Carcinoma
Author Information
Author(s): Peter Clifford, B. V. Bhardwaj, L. R. Whittaker
Primary Institution: The Kenyatta National Hospital, Nairobi, Kenya
Hypothesis
Can abdominal aortic occlusion enhance the effectiveness of nitrogen mustard therapy in treating nasopharyngeal carcinoma?
Conclusion
The study found that using abdominal aortic occlusion with nitrogen mustard therapy resulted in significant tumor regression in patients with nasopharyngeal carcinoma.
Supporting Evidence
- Thirty-one patients had effective palliation and twenty-eight were discharged clinically and histologically free of disease.
- Eight patients were discharged from hospital without evidence of disease after receiving 5.0 mg/kg HN2.
- Neuropathological examination showed cerebrovascular lesions in patients who received high doses of HN2.
Takeaway
Doctors used a special technique to help a medicine work better for patients with a type of throat cancer, and many got better.
Methodology
Patients received nitrogen mustard (HN2) with abdominal aortic occlusion to protect bone marrow and increase drug effectiveness.
Limitations
The study had limitations including the risk of severe complications and the inability to safely increase the dosage of HN2 due to cerebral toxicity.
Participant Demographics
Patients were primarily from Kenya with advanced nasopharyngeal carcinoma.
Want to read the original?
Access the complete publication on the publisher's website